Some patients report a temporary increase in fatigue or mild headache in the first few days, which resolves without intervention
As far as whether the pill will replace injections, Kidambi doesnt think so
Voxelotor is contraindicated in patients with a history of severe drug hypersensitivity or those taking fluconazole, ketoconazole, or rifampin
In individuals with type 2 diabetes, another phase 2 clinical study demonstrated that after 12 weeks of efinopegdutide treatment, although no significant improvement in glycated hemoglobin (HbA1c) levels was observed, the effect on weight loss reached a high of 7.9%, well above the 0.7% weight reduction rate in the placebo group
FEBS Lett (1987) 211(2):16974
Theres a new, statement from the Lancet commission on Obesity that came out, this past year